Skip to search formSkip to main contentSkip to account menu

WY-4036

Known as: WY 4036, WY4036 
National Institutes of Health

Related topics

Related topics

20 relations

Broader (11)

Anti-Anxiety AgentsAnticonvulsantsAntiemeticsBenzodiazepines
AtivanD-12524Lorazepam 0.5 MG Oral TabletLorazepam 2 MG/ML Oral Solution

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Comparative metabolism of lorazepam in man and four animal species.
The metabolic disposition of lorazepam (Wy-4036) in man, dog, cat, rat and miniature swine is compared. Except in the cat… 
1976
1976
A double-blind crossover controlled study of lorazepam (Wy 4036) and diazepam
SummaryA double-blind crossover trial was carried out in 21 hospitalised patients suffering from various psychoneurotic… 
1975
1975
Serum Concentration of Lorazepam (Wy-4036) in Humans and Urine Recovery of the Drug Following Oral Administration
Since benzodiazepin compounds have been used as tranquilizer, they are beeing defined compounds which quiet abnormal excitement… 
1972
1972
[Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium)].
1971
1971
Wy 4036 (lorazepam): a study of its use in premedication.
In 150 otherwise healthy gynaecological patients the sedative properties of a new benzodiazepine, lorazepam, have been studied… 
1971
1971
Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy 4036).
1971
1971
[Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group].
1971
1971
[Clinical studies on Wy 4036 (lorazepam), a new tranquilizing agent].
1971
1971
[Experience with the new tranquilizing agent Wy 4036 (lorazepam) in the specialties psychiatric neurology and internal medicine].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)